Highlights
IIA supported (ever)1 patent
About
Subcutaneous Implantable Cardioverter Defibrillator
NewPace develops a flexible and subcutaneous implantable cardioverter defibrillator (ICD) with no leads within the heart with a wireless rechargeable battery and Bluetooth communication.
The NewPace defibrillator differs from standard ICDs in that it does not have leads in the heart. The rechargeable device is implanted subcutaneously with no need for fluoroscopy and communicates via Bluetooth with a smartphone. The string-shaped defibrillator requires one hour per year for wireless recharge and communicates at low energy with smartphones for monitoring. The subcutaneous implantation requires no in-patient care.
NewPace partners with China-based Haisco Pharmaceutical.
Identity
| Name | Newpace |
|---|---|
| Slug | newpace |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgM_y-pcKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Caesarea |
| HQ address | Granit Street 13, Caesarea, Israel |
Web & social
| Website | https://www.newpacemedical.com |
|---|---|
| Careers page | https://www.newpacemedical.com |
| https://www.linkedin.com/company/28123492 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife Support
Technologies
CommunicationsBluetoothMaterials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business models
B2BB2B2C
Tags
medical-devicesheart-failuredoctorshospitalsmonitoringbluetoothcardiologywireless-communicationpatientschronic-patients
Funding
| Total raised | $2.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}